Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · Real-Time Price · USD
3.680
+0.410 (12.54%)
At close: Jan 17, 2025, 4:00 PM
3.690
+0.010 (0.27%)
After-hours: Jan 17, 2025, 6:35 PM EST

Revance Therapeutics Employees

Revance Therapeutics had 597 employees as of December 31, 2023. The number of employees increased by 63 or 11.80% compared to the previous year.

Employees
597
Change (1Y)
63
Growth (1Y)
11.80%
Revenue / Employee
$430,394
Profits / Employee
-$308,943
Market Cap
386.04M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20235976311.80%
Dec 31, 2022534397.88%
Dec 31, 2021495255.32%
Dec 31, 2020470277143.52%
Dec 31, 20191932313.53%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Related Stocks

Company Name Employees
UnitedHealth Group 440,000
Johnson & Johnson 131,900
Thermo Fisher Scientific 122,000
Abbott Laboratories 114,000
AstraZeneca 89,900
Novartis AG 76,057
Merck & Co. 72,000
Novo Nordisk 64,319
Employee Rankings